Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 5Completed 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 5Pancreatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Melanoma 4Neoplasm Metastasis 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Sarcoma 1Resectable Pancreatic Cancer 1Recurrent Bladder Urothelial Carcinoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, Non-Hodgkin 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Merkel Cell 1Brain Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1

Interventions

Paclitaxel 5Radiotherapy 3Fluorouracil 3Carboplatin 3nimotuzumab 2Taxes 2S 1 (combination) 2Radiation 2Oxaliplatin 2Nivolumab 2Ferrosoferric Oxide 2Drug Therapy 2Cisplatin 2Cetuximab 2pembrolizumab 1entinostat 1atezolizumab 1apatinib 1Watchful Waiting 1Trastuzumab 1TH 302 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Polymerase Chain Reaction 1Observation 1Nimodipine 1Magnetic Resonance Spectroscopy 1Lubricant Eye Drops 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Esophageal Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT02033538 2015-03-05

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus

Zhejiang University

Phase 2 Withdrawn
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡